Masthead
For informational use only

An editorial briefing on the
medical industry.

protonmeds.com is a small, independent publication tracking the global medical and pharma industry. It is not a journal, not a consulting product, and not a substitute for professional advice. It is a careful, dated, source-linked editorial brief — and that is the entire scope.

Editorial mission

The healthcare news cycle is enormous and unrelenting. On any given week there are dozens of conferences, hundreds of trial updates, and thousands of press releases. protonmeds.com exists to separate signal from noise — to track the same set of companies, regulators, and conferences over time, and to write about them carefully when something meaningful changes.

The editors believe a slower, more considered brief still has a place. Stories are filed only when there is a primary source to cite, and only when there is something a careful reader would actually want to know. Everything else stays out of the archive.

Editorial team

The desk

RS

Dr. Rina Sato

Editor-in-Chief

Former clinical researcher. Writes about pharma pipelines and reads every footnote.

MR

Marcus Reiner

Industry Reporter

Covers expos, partnerships, and the IR decks public pharma companies wish were private.

HP

Hana Park

Devices Beat

Tracks medical hardware, imaging, and surgical robotics from regulatory file to launch.

What the publication tracks

Four categories, kept separate

Expo

Major medical and pharma tradeshows — coverage of announcements, exhibitors, and the calendar to watch.

Pharma

Rising biotech and pharma companies, with notes on pipelines, partnerships, and funding rounds.

Research

Clinical trial updates and academic papers worth knowing about, summarized in plain language.

Devices

Medical hardware, imaging, surgical robotics, and wearables that change how care is delivered.

Sources the desk relies on

Primary, public, and verifiable

  • 01

    Conference programs (HIMSS, RSNA, MEDICA, BIO, JPM Healthcare)

  • 02

    Regulatory bulletins (FDA, EMA, MFDS press releases)

  • 03

    Public company filings and IR decks

  • 04

    Peer-reviewed journals (open access, abstract-level only)

  • 05

    Industry newsletters and credible health journalism

No paywalled content is quoted in full. Where the publication summarizes, it links to the original so readers can verify and update.

Editorial principles

Four rules the desk keeps

Cite the primary source

Coverage requires a link to a paper, an SEC filing, a press release, or a conference page. No primary source, no story.

Stay in the lane

The publication summarizes. It does not diagnose, recommend treatment, or give investment advice.

Plain language

Acronyms are expanded the first time. Jargon gets a one-line definition. Briefings should be readable on a tired Tuesday.

Date everything

Medical news ages fast. Every note carries a date stamp and a source link so readers can verify and update.

A note on scope

protonmeds.com covers the medical and pharmaceutical industry as a reader would — not as a practitioner. Reporting is not medical advice and is not investment guidance. For decisions that actually require either, consult a qualified professional.